SUBSCRIBE
SUBSCRIBE

Immunic Therapeutics

NEWS
Multiple sclerosis damaged myelin or MS autoimmune disease with healthy nerve with exposed fibre with scarrred cell sheath loss as a 3D illustration.
Multiple sclerosis
Beyond BTK Inhibitors: Next Gen MS Treatments Could Transcend Symptom Management
While Bruton’s tyrosine kinase inhibitors are often hailed as the next big breakthrough in multiple sclerosis, Immunic Therapeutics and others are leveraging neuroprotective targets and remyelination to keep the disease at bay.
October 6, 2025
 · 
5 min read
 · 
Ben Hargreaves
IN THE PRESS
Pharm Country
Immunic to Participate in Scientific Conferences in October 2023
October 4, 2023
 · 
6 min read
Load More
JOBS